Search

Displaying all 3 results
DrugBest match

Elranatamab

go.drugbank.com/drugs/DB15395
ApprovedInvestigational

Elranatamab is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. It is a humanized immunoglobulin 2-alanine kappa antibody derived from two monoclonal antibodies (mAbs), an anti-BCMA mAb and an anti-CD3 mAb, each of which contributes one heavy chain and one light chain to drug structure. The...

  1. Indication

    Relapsed Multiple Myeloma

    go.drugbank.com/conditions/DBCOND0031510
    Drugs: Belantamab mafodotin · Carfilzomib · Ciltacabtagene autoleucel · Daratumumab · Dexamethasone · Elranatamab +8 more
  2. Indication

    Refractory Multiple Myeloma

    go.drugbank.com/conditions/DBCOND0028542
    Drugs: Belantamab mafodotin · Carfilzomib · Carmustine · Ciltacabtagene autoleucel · Daratumumab · Dexamethasone +11 more